Related by context. Frequent words. (Click for all words.) 65 Azedra 64 Phase Ib clinical 63 VIAject 63 Pivotal Phase III 62 ATL# [001] 62 Amrubicin 62 IND submission 61 tesmilifene 61 phase IIa 61 dalbavancin 60 romidepsin 60 Phenoptin 60 Erlotinib 60 methylnaltrexone 60 KRN# 60 BNC# 60 Clevudine 59 IPLEX 59 tanespimycin 59 Phase IIa trial 59 anticancer compound 59 Avastin bevacizumab 59 Pivotal Phase 59 registrational trial 59 OncoVEX GM CSF 59 Heplisav 59 Phase III Clinical Trial 59 CCX# 59 elotuzumab 59 Natalizumab 59 registrational 59 mTOR inhibitor 59 liprotamase 59 KNS # 59 AP# [003] 58 Cethromycin 58 CoFactor 58 phase IIb 58 double blinded placebo 58 pertuzumab 58 Laquinimod 58 BrachySil 58 Bortezomib 58 Zolinza 58 Neurodex 58 Sym# 58 Hycamtin 58 Phase 1b clinical 58 Asentar 58 tocilizumab 58 Carfilzomib 58 Complete Response 58 HuMax CD# 58 Phase 2b study 58 decitabine 58 Vilazodone 58 QNEXA 58 daptomycin 57 GSK# [001] 57 thymalfasin 57 NVA# 57 maribavir 57 Phase 2b trial 57 Icatibant 57 MIRCERA 57 Mylotarg 57 alvimopan 57 Phase III 57 ataluren 57 interferon beta 1b 57 Telavancin 57 pharmacokinetic studies 57 placebo controlled clinical 57 Treanda 57 metastatic hormone refractory 57 BAY #-# 57 Zemiva 57 ponatinib 57 Cloretazine R VNP#M 57 Targretin 57 topical formulation 57 Pivotal Trial 57 axitinib 57 FDA Accepts 57 prospective multicenter 57 phase 2a 57 Phase 2a trial 57 clofarabine 57 GV# [001] 57 Restanza 57 Bevacizumab 57 Herceptin trastuzumab 57 Clolar 57 Pirfenidone 57 RSD# 57 Advexin 57 eltrombopag 56 relapsed refractory multiple myeloma 56 OPAXIO 56 ONTAK 56 Metastatic Melanoma